Theyre not interchangeable, and neither is universally better
Certificate of Analysis on every batch
Regulatory and safety status: Emideltide is not approved for use in humans and is currently pending FDA review
Consulting with healthcare providers familiar with peptide research can help contextualize individual risks and benefits
It not only acts on the GLP-1 receptors but also on the GIP receptors, offering a broader range of metabolic benefits
Insulitis is classified as 15 CD45+ cells per islet in a minimum of three islets ( In humans, roughly 20-30% of insulin-containing islets have been shown to exhibit insulitis compared to 2.9% in insulin-deficient islets ( 3 The genetic landscape of T1D: from risk scores to functional pathways Predisposition to T1D is caused by genetic susceptibility in multiple loci, including INS , IFIH1 , and the class I and II HLA genes ( 3.1 T1D-associated genes: impact on immune function Approximately 40-50% of the genetic risk of developing T1D is attributed to the class I and II MHC/HLA region, with class II being the most significant, as it is essential to the adaptive immune system ( Figure 1 ) ( HLA-DR , HLA-DQ , and HLA-DP loci ( HLA-DPB1 locus also contributes to risk, though its effect is less profound than the DR and DQ loci, with DPB1*0301 and DPB1*0202 associated with risk and DPB1*0402 acting as a protective allele in DR3 carrying patients ( After the HLA genes, the INS locus confers the highest genetic risk of developing T1D ( Figure 1 ) ( INS gene and the 11p15.5 genetic regionharboring the INS and the INS-IGF2 genesrespectively ( IDDM2 locus, which corresponds to the allelic variation at the INS variable number of tandem repeats (VNTR) ( INS gene and proinsulin protein in the thymus and lower expression in the pancreas of human patients harboring the class III allele compared to class I expression
